Pfizer Partners With Clear Creek Bio to Develop Oral COVID-19 Drug
Pfizer and Clear Creek Bio on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as Pfizer seeks to expand its anti-infective pipeline.